查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1372853

蛋白质表征和鑑定市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按产品和服务、按应用、最终用途、地区和竞争细分

Protein Characterization and Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product & Services, By Application, By End-Use, By Region, and By Competition
出版日期: | 出版商: TechSci Research | 英文 190 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年蛋白质表征和鑑定市场估值为140.2 亿美元，预计到2028 年将以13.65% 的复合年增长率实现显着增长。这一预测归因于生物製剂和蛋白质组学领域对蛋白质表征和鑑定的不断升级，以及政府对蛋白质体学研究的大量投资，反过来又支持了蛋白质表征和鑑定行业的扩张。此外，市场的上升轨迹得益于对一系列策略的日益重视，包括推出新颖产品、合作伙伴关係和协同合作，所有这些都有望在整个预测时间内促进大幅成长。

同样值得注意的是，随着政府资助，製药领域的研发支出激增。再加上蛋白质体学领域固有的广阔前景以及蛋白质技术的不断进步，共同构成了推动市场在预测期内扩张的关键力量。

因此，这些决定因素的累积效应将引导蛋白质表征和鑑定市场走向强劲成长的轨道，释放巨大的潜力，并在规定的预测期内建立一个引人注目的模式。

市场概况
预测期 2024-2028
2022 年市场规模 140.2亿美元
2028 年市场规模 301.6亿美元
2023-2028 年复合年增长率 13.65%
成长最快的细分市场 製药与生物技术公司
最大的市场 北美洲

慢性病盛行率增加

癌症、糖尿病和心血管疾病等慢性疾病对全球蛋白质表征和鑑定市场的扩张有重大影响。这些疾病的特征是蛋白质表现的改变、翻译后修饰和相互作用，所有这些都为疾病诊断、治疗介入和药物进步提供了宝贵的见解。蛋白质表征和鑑定过程在破解慢性疾病的分子基础方面发挥关键作用，包括识别疾病特异性生物标记、潜在药物标靶和复杂途径。此外，对蛋白质及其相互作用的全面了解也为了解疾病的进展和治疗抗药性的出现提供了宝贵的线索。

个人化医疗需求不断成长

个人化医疗迅速兴起，是一个迅速发展的领域，旨在提供基于患者基因组成、生活方式和其他相关因素的客製化治疗。个人化医疗立基于蛋白质表征和鑑定领域，对全球蛋白质表征和鑑定市场的扩张产生了深远的影响。在错综复杂的个人化医疗结构中，蛋白质表征和鑑定发挥着不可或缺的作用，支撑着疾病特异性生物标记的发现和精确定制的治疗干预措施的发展。透过细緻地揭示蛋白质及其复杂的相互作用，研究人员有能力找出疾病进展过程中缠绕的特定蛋白质，随后制定选择性地与这些蛋白质结合的标靶疗法。

此外，包括质谱和色谱在内的新型蛋白质组学技术的推动，构成了推动全球蛋白质表征和鑑定市场成长的动力。这些创新使研究人员在检查蛋白质方面具有更高的精度和灵敏度，这是个人化医疗发展至关重要的一个方面。

对个人化医疗不断增长的需求不仅正在塑造其自身的发展轨迹，而且也是引导全球蛋白质表征和识别市场扩张的重要因素。个人化医疗旨在提供针对患者遗传体质、生活方式和其他背景因素的独特治疗方法，其基石是蛋白质表征和鑑定，可作为查明疾病生物标记和製定针对性疗法的管道。此外，慢性病盛行率的激增凸显了对创新、有效疗法的需求，从而推动了对蛋白质表征和鑑定的需求。慢性疾病的特征是蛋白质表现的变化、翻译后修饰和复杂的相互作用，为疾病诊断、治疗干预和药物突破提供了关键资料。

蛋白质体学技术的进步

全球蛋白质表征和鑑定市场的扩张受到蛋白质体技术进步的显着影响。这些技术包含一系列用于研究给定样品中蛋白质的配置、操作和相互作用的工具和方法。新型蛋白质组学技术的发展，特别是质谱和色谱法，使研究人员能够以更高的精度和灵敏度检查蛋白质。这项进展释放了在比以前可行的浓度明显更低的浓度下检测和测量蛋白质的能力，从而大大拓宽了蛋白质表征和鑑定的领域。这些技术所表现出的卓越精确度和独特性是找出疾病特异性生物标记和设计有针对性的治疗介入措施的先决条件。

透过应用蛋白质体学技术，研究人员能够找到有助于疾病进展的不同蛋白质，从而能够制定选择性地与这些蛋白质结合的疗法。这种以精准医学为基础的细緻方法有可能大幅提高患者的治疗效果并减轻与传统治疗相关的风险。

此外，蛋白质体学技术在药物开发领域的应用也推动了全球蛋白质表征和鑑定市场的成长轨迹。透过剖析蛋白质和潜在候选药物之间的相互作用，研究人员可以识别具有最佳治疗潜力的化合物并完善其药理学属性。

同时，对个人化医疗的需求不断增长，在推动全球蛋白质表征和鑑定市场的扩张方面发挥关键作用。蛋白质体学技术的成熟为识别疾病特异性生物标记和製定标靶治疗方法铺平了道路，这两者构成了个性化医疗领域的基本组成部分。

更加重视研究和开发

研发 (R&D) 努力的推动力是不可否认的，推动了全球蛋白质表征和鑑定市场的成长轨迹。随着对蛋白质表征和鑑定的需求不断升级，对能够提供更快速、更精确和全面的蛋白质分析的创新技术和方法的需求也越来越大。对研发的投入催生了专为蛋白质表征和鑑定而定制的新型工具和技术，从而扩大了市场的能力。值得注意的是，质谱、蛋白质微阵列和蛋白质成像方法等开创性蛋白质体学技术的出现，精心策划了蛋白质分析的变革，使研究人员对蛋白质的复杂性有了前所未有的见解。

这种转变的一个显着例子是药物开发领域，其中蛋白质体学的应用正在迅速成长。许多製药企业正在大力投资建构蛋白质体驱动的药物发现平台。此外，蛋白质表征和鑑定正在向农业、食品科学和环境科学等多个领域取得重大进展。同时，学术和研究机构正在坚定不移地将资源投入研发计划，推动蛋白质表征和鑑定的前沿发展。这种热烈的参与促进了新颖的研究工具、技术和方法的出现，这些工具、技术和方法不仅扩大了市场领域，而且显着丰富了其成长轨迹。

政府资助的可用性

全球蛋白质表征和鑑定市场受到政府资助的显着影响，这是成长的重要动力。资金的提供可以起到多种作用的催化剂，包括支持研究和开发工作、促进新技术的采用以及创新产品和服务的快速商业化。政府资助透过向研究机构和大学提供财政支持而发挥着特别突出的作用。这种支持有助于学术研究，进而为蛋白质表征和鑑定的新技术和方法的出现铺平道路。这种催化过程导致新的生物标记的发现和针对多种疾病的针对性治疗策略的製定，从而推动市场扩张。

另一方面，政府资助在推动突破性产品和服务的商业化方面发挥关键作用。这种金融支持延伸至中小企业（SME），促进其产品的构思和行销。这种方法不仅有利于新技术和方法的吸收，而且还培养了创新环境。例如，政府资金的支持可以促进新的质谱或色谱仪器的创建，有助于降低分析成本并提高蛋白质鑑定的精确度。

此外，政府资助透过促进学术界、工业界和政府实体之间的合作和伙伴关係来扩大其影响力。这些策略联盟刺激创新，促进知识交流，并加速开创性技术和方法的开发和商业化。在蛋白质表征和鑑定市场的宏伟织锦中，政府提供的财政支持错综复杂地编织而成，不仅可以促进成长，还可以推动变革性进步的出现。

市场区隔

全球蛋白质表征和鑑定市场可以根据产品和服务、应用、最终用途和地区进行细分。根据产品和服务，市场可以分为消耗品、仪器和服务。根据应用，市场可分为药物发现与开发、临床诊断等。根据最终用途，市场进一步分为製药和生物技术公司、学术研究机构、合约研究组织等。

市场参与者

Agilent Technologies、Analytik Jena、Bio-Rad Laboratories、Bruker Corporation、Cleaver Scientific、Danaher Corporation、Eurofins Scientific、Horiba、Jeol、Merck KGaA、PerkinElmer Inc、Promega Corporation、Qiagen NV 是全球蛋白质领域的一些领先参与者和表征市场。

报告范围：

在本报告中，除了下面详细介绍的行业趋势外，全球蛋白质表征和鑑定市场还分为以下几类：

蛋白质表征和鑑定市场，按产品和服务划分：

  • 耗材
  • 仪器
  • 服务仪器

蛋白质表征与鑑定市场（按应用）：

  • 药物发现与开发
  • 临床诊断
  • 其他的

蛋白质表征和鑑定市场，按最终用途：

  • 製药和生物技术公司
  • 学术研究机构
  • 合约研究组织
  • 其他的

蛋白质表征与鑑定市场（按地区）：

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 欧洲
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

竞争格局

  • 公司简介：对全球蛋白质表征和鑑定市场中主要公司的详细分析。

可用的客製化：

  • 根据给定的市场资料，TechSci Research 可根据公司的具体需求提供客製化服务。该报告可以使用以下自订选项：

公司资讯

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球蛋白质表征与鑑定市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按产品和服务
    • 按应用
    • 按最终用途
    • 按地区

第 6 章：北美蛋白质表征与鑑定市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲蛋白质表征与鑑定市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第 8 章：亚太地区蛋白质表征与鑑定市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第 9 章：南美洲蛋白质表征与鑑定市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲蛋白质表征和鑑定市场前景

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依产品及服务（消耗品、仪器、服务）
    • 按应用（药物发现与开发、临床诊断、其他）
    • 依最终用途（製药和生物技术公司、学术研究机构、合约研究组织、其他）
    • 按国家/地区
  • MEA：国家分析
    • 南非蛋白质表征和鑑定
    • 沙乌地阿拉伯蛋白质表征和鑑定
    • 阿联酋蛋白质表征和鑑定

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：全球蛋白质表征与鑑定市场：SWOT 分析

第 14 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第15章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Agilent Technologies
    • Analytik Jena
    • Bio-Rad Laboratories
    • Bruker Corporation
    • Cleaver Scientific
    • Danaher Corporation
    • Eurofins Scientific
    • Horiba
    • Jeol
    • Merck KGaA
    • PerkinElmer Inc
    • Promega Corporation
    • Qiagen NV

第 16 章：策略建议

简介目录
Product Code: 15523

Protein characterization and Identification market was valued at USD 14.02 Billion in 2022, and is poised for remarkable growth with a CAGR Of 13.65% by 2028. This projection is attributable to the escalating embrace of protein characterization and identification within the biologics and proteomics sectors, complemented by substantial investments by governments in proteomics research, which in turn buttresses the expansion of the protein characterization and identification industry. Furthermore, the market's upward trajectory gains momentum from the increasing emphasis on a spectrum of strategies, including the introduction of novel products, collaborative partnerships, and synergistic collaborations, all of which are poised to foster substantial growth throughout the forecast timeframe.

Equally noteworthy is the surge in research and development expenditure within the pharmaceutical domain, in tandem with governmental funding. This, coupled with the promising prospects inherent in the proteomics field and the ongoing advancements in protein technology, collectively constitute pivotal forces propelling the market's expansion over the forecast duration.

Consequently, the cumulative effect of these determinants is set to steer the protein characterization and identification market toward a trajectory of robust growth, unlocking considerable potential and establishing a striking landscape within the stipulated forecast period.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 14.02 Billion
Market Size 2028USD 30.16 Billion
CAGR 2023-202813.65%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

Increasing prevalence of chronic diseases

Chronic ailments, such as cancer, diabetes, and cardiovascular disorders, wield a substantial influence over the expansion of the Global Protein Characterization and Identification Market. These conditions are distinguished by alterations in protein expression, post-translational modifications, and interactions, all of which proffer valuable insights for disease diagnosis, therapeutic interventions, and pharmaceutical advancement. The process of protein characterization and identification plays a pivotal role in deciphering the molecular underpinnings of chronic ailments, encompassing the discernment of disease-specific biomarkers, potential drug targets, and intricate pathways. Moreover, the comprehensive understanding of proteins and their interplay also furnishes invaluable glimpses into the progression of maladies and the emergence of resistance to treatments.

The escalating prevalence of chronic diseases underscores the heightened demand for protein characterization and identification. According to the World Health Organization (WHO), chronic ailments account for 71% of global fatalities, and this figure is poised to surge in the years ahead. This escalating burden imposed by chronic diseases has triggered a call for novel and efficacious therapies, consequently escalating the requisition for protein characterization and identification.

Furthermore, the burgeoning aspiration for personalized medicine contributes to the burgeoning growth of the global Protein Characterization and Identification market. Personalized medicine strives to deliver tailored treatments based on a patient's genetic composition, lifestyle, and other influencing factors. The process of protein characterization and identification occupies a vital role in sculpting personalized medicine's landscape, offering a platform for the identification of disease-specific biomarkers and the formulation of precisely targeted therapies.

Growing demand for personalized medicine

Emerging at a swift pace, personalized medicine stands as a rapidly burgeoning realm, geared toward furnishing customized treatment grounded in a patient's genetic composition, lifestyle, and other relevant factors. Anchored in the domain of protein characterization and identification, personalized medicine exerts a profound influence on the expansion of the global Protein Characterization and Identification market. In the intricate tapestry of personalized medicine's fabric, protein characterization and identification play an indispensable role, underpinning the discovery of disease-specific biomarkers and the formulation of precisely tailored therapeutic interventions. Through the meticulous unraveling of proteins and their intricate interplays, researchers are endowed with the capability to pinpoint particular proteins entwined in the course of disease progression, subsequently forging targeted therapies that selectively engage with these proteins.

Moreover, the propulsion of novel proteomic technologies, including mass spectrometry and chromatography, constitutes a dynamic force driving the growth of the global Protein Characterization and Identification market. These innovations equip researchers with heightened precision and sensitivity in scrutinizing proteins, an aspect of paramount importance in the evolution of personalized medicine.

The escalating demand for personalized medicine is not only shaping its own trajectory but is also an instrumental factor steering the expansion of the Global Protein Characterization and Identification Market. Aiming to deliver treatments uniquely molded to a patient's genetic constitution, lifestyle, and other contextual elements, personalized medicine finds its cornerstone in protein characterization and identification, serving as a conduit to pinpointing disease biomarkers and honing targeted remedies. Additionally, the surging prevalence of chronic diseases casts a spotlight on the demand for innovative, efficacious therapies, thus fanning the need for protein characterization and identification. Chronic illnesses, hallmarked by shifts in protein expression, post-translational modifications, and intricate interactions, proffer a reservoir of pivotal data for disease diagnosis, therapeutic interventions, and pharmaceutical breakthroughs.

Advancements in proteomic technologies

The expansion of the global Protein Characterization and Identification market has been significantly influenced by the strides achieved in proteomic technologies. These technologies encompass an array of tools and methodologies employed to investigate the configuration, operation, and interplays of proteins within a given sample. The evolution of novel proteomic technologies, notably exemplified by mass spectrometry and chromatography, has empowered researchers to scrutinize proteins with heightened precision and sensitivity. This progression has unleashed the capacity to detect and gauge proteins at markedly lower concentrations than previously feasible, thereby substantially broadening the realm of protein characterization and identification. The exceptional precision and distinctiveness exhibited by these technologies stand as prerequisites for pinpointing disease-specific biomarkers and engineering targeted therapeutic interventions.

Through the application of proteomic technologies, researchers are endowed with the means to pinpoint distinct proteins that contribute to the advancement of diseases, enabling the formulation of therapies that selectively engage with these proteins. This meticulous approach, anchored in precision medicine, bears the potential to profoundly elevate patient outcomes and alleviate the risks associated with conventional treatments.

Moreover, the utilization of proteomic technologies in the domain of drug development has also propelled the growth trajectory of the Global Protein Characterization and Identification Market. By dissecting the interactions between proteins and potential drug candidates, researchers can discern compounds boasting optimal therapeutic potential and refine their pharmacological attributes.

Simultaneously, the surging demand for personalized medicine plays a pivotal role in steering the expansion of the global Protein Characterization and Identification market. The maturation of proteomic technologies has paved the way for the identification of disease-specific biomarkers and the formulation of targeted therapeutic approaches, both of which constitute fundamental components of personalized medicine's landscape.

Increasing focus on research and development

Driving the growth trajectory of the global Protein Characterization and Identification market, the impetus stemming from research and development (R&D) endeavors is undeniable. As the demand for protein characterization and identification escalates, the imperative for inventive technologies and methodologies intensifies, ones capable of delivering swifter, more precise, and all-encompassing protein analyses. The infusion of investments into R&D pursuits has engendered the emergence of novel tools and techniques tailor-made for protein characterization and identification, thereby amplifying the market's capabilities. Notably, the advent of pioneering proteomic technologies such as mass spectrometry, protein microarrays, and protein imaging methods has orchestrated a transformation in protein analysis, granting researchers unprecedented insights into protein intricacies.

A striking illustration of this transformation lies in the sphere of drug development, wherein the employment of proteomics is rapidly gaining momentum. Numerous pharmaceutical enterprises are making substantial investments in the crafting of proteomic-driven drug discovery platforms. Furthermore, protein characterization and identification are making substantial inroads into diverse sectors including agriculture, food science, and environmental science. Concurrently, academic and research institutions are steadfastly channeling resources into R&D initiatives, propelling the frontiers of protein characterization and identification. This fervent engagement has fostered the emergence of novel research tools, technologies, and methodologies that have not only expanded the market's realm but have also markedly enriched its growth trajectory.

Availability of government funding

The global Protein Characterization and Identification market experiences a notable influence from government funding, signifying a significant driver of growth. The availability of funding serves as a catalyst for manifold effects, including the bolstering of research and development endeavors, the facilitation of new technology adoption, and the expeditious commercialization of innovative products and services. Government funding exercises a particularly prominent role by providing financial backing to research institutions and universities. This support aids academic research, which in turn paves the way for the emergence of novel technologies and methodologies geared toward protein characterization and identification. This catalytic process leads to the unearthing of fresh biomarkers and the formulation of targeted therapeutic strategies across a diverse spectrum of ailments, thereby propelling market expansion.

Government funding, in another vein, plays a pivotal part in propelling the commercialization of groundbreaking products and services. Such financial support extends to small and medium-sized enterprises (SMEs), facilitating the conception and marketing of their offerings. This approach not only eases the assimilation of novel technologies and methodologies but also nurtures an environment of innovation. For instance, the backing of government funding can precipitate the creation of new mass spectrometry or chromatography instruments, thereby contributing to reduced analysis costs and heightened precision in protein identification.

Furthermore, government funding extends its influence by fostering collaborations and partnerships among academia, industry, and government entities. These strategic alliances spur innovation, foster the exchange of knowledge, and expedite the development and commercialization of pioneering technologies and approaches. In the grand tapestry of the Protein Characterization and Identification market, the financial support provided by governments intricately weaves a fabric that not only catalyzes growth but also fuels the emergence of transformative advancements.

Market Segmentation

Global Protein Characterization and Identification market can be segmented on the basis of product and service, application, end use and by region. Based on the product and service, the market can be segmented into consumables, instruments, and services. Based on application, the market can be segmented into drug discovery & development, clinical diagnosis, and others. Based on end use, the market is further divided into pharmaceuticals & biotechnology companies, academic research institutes, contract research organizations, and others.

Market Players

Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV are some of the leading players operating in the global Protein Characterization and Identification market.

Report Scope:

In this report, global Protein Characterization and Identification market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization and Identification Market, By Product and Service:

  • Consumables
  • Instruments
  • Services Instruments

Protein Characterization and Identification Market, By Application:

  • Drug Discovery & Development
  • Clinical Diagnosis
  • Others

Protein Characterization and Identification Market, By End Use:

  • Pharmaceuticals & Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Others

Protein Characterization and Identification Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the global Protein Characterization and Identification market.

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Characterization and Identification Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product & Services (Consumables, Instruments, Services)
    • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product & Services
    • 5.3.2 By Application
    • 5.3.3 By End Use
    • 5.3.4 By Region

6. North America Protein Characterization and Identification Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Services (Consumables, Instruments, Services)
    • 6.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 6.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Characterization and Identification Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Protein Characterization and Identification Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Protein Characterization and Identification Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Protein Characterization and Identification Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product & Services (Consumables, Instruments, Services)
    • 7.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 7.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Protein Characterization and Identification Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. Germany Protein Characterization and Identification Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Protein Characterization and Identification Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Protein Characterization and Identification Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Protein Characterization and Identification Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia-Pacific Protein Characterization and Identification Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product & Services (Consumables, Instruments, Services)
    • 8.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 8.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Protein Characterization and Identification Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Protein Characterization and Identification Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Protein Characterization and Identification Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Protein Characterization and Identification Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Protein Characterization and Identification Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. South America Protein Characterization and Identification Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product & Services (Consumables, Instruments, Services)
    • 9.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 9.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Protein Characterization and Identification Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. Argentina Protein Characterization and Identification Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. Colombia Protein Characterization and Identification Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. Middle East and Africa Protein Characterization and Identification Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product & Services (Consumables, Instruments, Services)
    • 10.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
    • 10.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Protein Characterization and Identification Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Saudi Arabia Protein Characterization and Identification Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. UAE Protein Characterization and Identification Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Protein Characterization and Identification Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Agilent Technologies
    • 15.6.2 Analytik Jena
    • 15.6.3 Bio-Rad Laboratories
    • 15.6.4 Bruker Corporation
    • 15.6.5 Cleaver Scientific
    • 15.6.6 Danaher Corporation
    • 15.6.7 Eurofins Scientific
    • 15.6.8 Horiba
    • 15.6.9 Jeol
    • 15.6.10 Merck KGaA
    • 15.6.11 PerkinElmer Inc
    • 15.6.12 Promega Corporation
    • 15.6.13 Qiagen NV

16. Strategic Recommendations